Evidence map›Paper›PMID 38389884›Full record

ArticleRSC medicinal chemistry2024

Design, synthesis and biological evaluation of novel pyrimidine derivatives as bone anabolic agents promoting osteogenesis

Sumit K Rastogi, Sonu Khanka, Santosh Kumar, Amardeep Lakra, Rajat Rathur, Kriti Sharma, Amol Chhatrapati Bisen, Rabi Sankar Bhatta, Ravindra Kumar, Divya Singh and 1 more

Open access · greenAbstract read
In one paragraph

Article in RSC medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 7 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Sumit K RastogiDivision of Medicinal and Process Chemistry, CSIR-Central Drug Research Institute Lucknow 226031 India ravindra.kumar1@cdri.res.in aksinha08@rediffmail.com.
Sonu KhankaDivision of Endocrinology, CSIR-Central Drug Research Institute Lucknow 226031 India divya_singh@cdri.res.in.
Santosh KumarDivision of Medicinal and Process Chemistry, CSIR-Central Drug Research Institute Lucknow 226031 India ravindra.kumar1@cdri.res.in aksinha08@rediffmail.com.
Amardeep LakraDivision of Endocrinology, CSIR-Central Drug Research Institute Lucknow 226031 India divya_singh@cdri.res.in.
Rajat RathurDivision of Endocrinology, CSIR-Central Drug Research Institute Lucknow 226031 India divya_singh@cdri.res.in.
Kriti SharmaDivision of Endocrinology, CSIR-Central Drug Research Institute Lucknow 226031 India divya_singh@cdri.res.in.
Amol Chhatrapati BisenAcademy of Scientific and Innovative Research (AcSIR) Ghaziabad 201002. U.P. India.
Rabi Sankar BhattaAcademy of Scientific and Innovative Research (AcSIR) Ghaziabad 201002. U.P. India.ORCID https://orcid.org/0000-0003-4844-2388
Ravindra KumarDivision of Medicinal and Process Chemistry, CSIR-Central Drug Research Institute Lucknow 226031 India ravindra.kumar1@cdri.res.in aksinha08@rediffmail.com.ORCID https://orcid.org/0000-0003-0290-679X
Divya SinghDivision of Endocrinology, CSIR-Central Drug Research Institute Lucknow 226031 India divya_singh@cdri.res.in.
Arun K SinhaDivision of Medicinal and Process Chemistry, CSIR-Central Drug Research Institute Lucknow 226031 India ravindra.kumar1@cdri.res.in aksinha08@rediffmail.com.ORCID https://orcid.org/0000-0002-1223-9495
Central Drug Research Institute · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anti-resorptive inhibitors such as bisphosphonates are widely used but they have limited efficacy and serious side effects. Though subcutaneous injection of teriparatide [PTH (1-34)] is an effective anabolic therapy, long-term repeated subcutaneous administration is not recommended. Henceforth, orally bio-available small-molecule-based novel therapeutics are unmet medical needs to improve the treatment. In this study, we designed, synthesized, and carried out a biological evaluation of 31 pyrimidine derivatives as potent bone anabolic agents. A series of

Identifiers

PMID38389884
PMCPMC10880903
OpenAlexW4390577741

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.